ADT
Androgen Deprivation Therapy (ADT), also known as hormone therapy, is a type of treatment primarily used to manage prostate cancer. ADT works by reducing the levels of androgens, male hormones, in the body, which can fuel the growth of prostate cancer cells. The most common androgens are testosterone and dihydrotestosterone (DHT).
Mechanism of Action[edit | edit source]
ADT can be achieved through several methods, including surgical removal of the testes (orchiectomy), which is a permanent form of ADT, or through the use of medications that either stop the production of androgens by the testes or block the action of androgens on their receptors. Medications used in ADT include Luteinizing Hormone-Releasing Hormone (LHRH) agonists, LHRH antagonists, and anti-androgens.
Indications[edit | edit source]
ADT is primarily indicated for the treatment of advanced prostate cancer, particularly in cases where the cancer has spread beyond the prostate gland (metastatic prostate cancer) or is at high risk of doing so. It is also used in combination with radiation therapy for intermediate to high-risk localized prostate cancer to improve outcomes.
Side Effects[edit | edit source]
The reduction of androgen levels can lead to several side effects, including hot flashes, reduced libido, erectile dysfunction, bone density loss, muscle mass loss, fatigue, and an increased risk of cardiovascular diseases and diabetes.
Controversies and Considerations[edit | edit source]
The use of ADT in treating prostate cancer is not without controversy. The potential side effects necessitate a careful consideration of the benefits and risks of this therapy. Ongoing research aims to optimize the timing and duration of ADT to maximize its benefits while minimizing adverse effects.
Future Directions[edit | edit source]
Research into ADT continues to evolve, with studies exploring intermittent ADT, which involves cycles of treatment followed by breaks, as a way to reduce side effects while still controlling the cancer. Additionally, new drugs and treatment combinations are being investigated to improve outcomes for patients with prostate cancer.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
